Key triggers are recovery in GRMs ahead of estimates, faster consolidation in telecom leading to tariff upside in Jio, possible public listing of Jio leading to re-rating valuation multiple, retail biz gaining market share faster than expected and Jiomart GMV beating expectation.
Aarti Pharmalabs shares rally over 33% in two days post Q1 results. What is driving the surge?
Aarti Pharmalabs shares have surged 33% in two days after the company reported a 65.4% year-on-year rise in Q1FY27 profit and 38.7% growth in revenue.